• Ex4 into the NTS inhibits the acute behavioral effects of alcohol in mice.
Introduction
Although the incretin hormone glucagon-like peptide-1 (GLP-1) has a vast set of functions, such as regulation of blood glucose through insulin secretion, (Kreymann et al., 1987) , reduction of glucagon secretion (Orskov et al., 1988) and inhibition of gastric emptying (Flint et al., 1998) , is also well known for its ability to decrease appetite and food intake (Holst, 2007; Pannacciulli et al., 2007) .
GLP-1 is produced in the enteroendocrine L-cells (Novak et al., 1987) and in neurons that originates in nucleus of the solitary tract (NTS) (Jin et al., 1988; Shughrue et al., 1996) . Within the NTS, a part of the caudal brainstem, GLP-1 is derived as a post-translational product from preproglucagon (Larsen et al., 1997) . Previous work has shown that activation of GLP-1 receptors (GLP-1R), within the medial and caudal NTS, causes a decline in food intake, inhibition of food reward (Alhadeff and Grill, 2014; Hayes et al., 2009; McMahon and Wellman, 1998; Richard et al., 2015; Tang-Christensen et al., 1996) as well as a decrease in nicotine intake in rats (Tuesta et al., 2017) .
In recent years activation of GLP-1R by various agonists such as exendin-4 (Ex4), liraglutide and AC3174 was found to block various alcohol-mediated behaviors in both mice and rats (Egecioglu et al., 2013c; Reddy et al., 2016; Shirazi et al., 2013; Suchankova et al., 2015; Thomsen et al., 2017; Vallof et al., 2016a) . Additional studies in mice and rats revealed that Alcohol induced (Alc, 1.75 g/kg, ip) a locomotor stimulation compared to vehicle (Veh). This stimulation was inhibited by NTS infusion of Ex4 (0.05 μg per side), at a dose with no effect per se. There was no difference in response between vehicle treated mice and those treated with Ex4 in combination with alcohol. (*P < 0.05, ***P < 0.001, P > 0.05 n.s. = non-significant, one-way ANOVA followed by Tukey post-hoc test). (C) Alcohol also caused a locomotor stimulation when analyzed over time, where an increase was observed at time points 30 and 50 min. The alcohol response was lower in NTS-Ex4 treated mice, specifically at time point 30 and 50 min. There was no difference in locomotor activity in vehicle and Ex4-alcohol treated mice. (*P < 0.05, ***P < 0.001 for vehicle-vehicle versus vehicle-alcohol and #P < 0.05, ##P < 0.01 for vehicle-alcohol versus Ex4-alcohol, repeated two-way ANOVA followed by Bonferroni post-hoc test). (D) NTS-Ex4 (0.05 μg per side), attenuated the memory of alcohol reward in the conditioned place preference (CPP) paradigm (*P < 0.05, un-paired t-test). (E) Alcohol caused a release of dopamine in nucleus accumbens (NAc) shell at time points 40-200 min. Ex4 (0.05 μg per side) into the NTS blocked the alcohol induced increase in NAc-dopamine release at time points 60-100 and at 180 min. There was no difference in response between vehicle treated mice and those treated with Ex4 and alcohol, and the selected dose of Ex4 had no effect per se on accumbal dopamine (*P < 0.05, **P < 0.01, when comparing Veh-Veh versus Veh-Alc; #P < 0.05, ###P < 0.001 for Veh-Alc versus Ex4-Alc, repeated two-way ANOVA followed by Bonferroni post-hoc test). All data are presented as mean ± SEM. abuse including nicotine, cocaine and amphetamine (Egecioglu et al., 2013a, b; Erreger et al., 2012; Graham et al., 2013; Sorensen et al., 2016; Sorensen et al., 2015) . A link between GLP-1 and drug-related behaviors in humans are provided by the findings that the GLP-1 levels are linked to the subjective experience in cocaine (Bouhlal et al., 2017) and that there are associations between GLP-1R polymorphisms and alcohol dependence as well as intravenous-self administration of alcohol in social drinkers (Suchankova et al., 2015) . In further support for the clinical use of GLP-1R agonists for treatment of addictions is a pilot study revealing that liraglutide decreases alcohol consumption diabetes type 2 patients (Kalra, 2011) . Albeit these previous studies show a link between GLP-1R and alcohol-related behaviors (for review see (Jerlhag, 2018) ), the neurocircuitry modulating these effects still remains unknown. Therefore, the present set of experiments was designed to broaden the knowledge of the functional role of subpopulations of GLP-1R within the NTS in alcohol-related behaviors in rodents. We explored the hypothesis that infusion of Ex4 into the NTS prevents alcohol-induced locomotor stimulation, accumbal dopamine release and memory consolidation of alcohol reward in the conditioned place preference (CPP) paradigm in male mice, known to respond profoundly to alcohol in these models (Egecioglu et al., 2013c; Vallof et al., 2016a) . In addition, the ability of Ex4 into NTS to reduce alcohol intake in the intermittent access model was evaluated in male rats, which are known to consume high levels of alcohol in this paradigm (Simms et al., 2008) .
Material and methods

Animals
Adult post-pubertal age-matched male NMRI mice (8-12 weeks old and 25-35 g body weight; Charles River, Susfeldt, Germany) maintained on a 12/12-h light/dark cycle (20°C and 50% humidity) were used for the locomotor activity, the in vivo microdialysis and CPP studies, since this strain displays a robust response to alcohol in these models (Egecioglu et al., 2013a; Jerlhag et al., 2009; Vallof et al., 2016b) . Adult post-pubertal male outbred Rcc Han Wistar rats (Envigo, Horst, Netherlands), known to voluntarily consume alcohol causing pharmacological relevant blood alcohol concentrations, were used for the intermittent access paradigm (Simms et al., 2008) . The rats were kept on a 12 h reversed light dark cycle (lights off at 10 a.m.) in rooms with a 20°C and 50% humidity. All animals had free access to food and water and were allowed to acclimatize at least one week before the initiation of the experiments. The Swedish Ethical Committee on Animal Research in Gothenburg approved all experiments. Independent set of animals was used for each separate experiment. Mice and rats were used in the present study, based on studies reporting a robust effect of alcohol in these models as well as a similar response to GLP-1R agonist treatment (Egecioglu et al., 2013c; Vallof et al., 2016a) .
Drugs
Alcohol (96%; VWR International AB, Stockholm, Sweden) was diluted in vehicle (saline; 0.9% NaCl) to 15% v/v for intraperitoneal (ip) injections and was administered at a dose of 1.75 g/kg five minutes prior to initiation of the experiments. For the intermittent access alcohol two-bottle-choice drinking paradigm alcohol was diluted to a 20% vol/vol solution using tap water. Ex4 (Tocris Bioscience, Bristol, England), a selective GLP-1R agonist with similar binding to GLP-1 (Goke et al., 1995; Thorens et al., 1993) , was diluted in vehicle (Ringer solution; NaCl 140 mM, Ca Cl 2 1.2 mM, KCl 3.0 mM and MgCl 2 1.0 mM; Merck KGaA, Darmstadt, Germany). Ex4, opposed to other GLP-1R agonists, was selected since it robustly blocks various alcohol-and drug-related behaviors in rodents (Egecioglu et al., 2013a, b; Egecioglu et al., 2013c; Erreger et al., 2012; Graham et al., 2013; Shirazi et al., 2013; Sorensen et al., 2016; Sorensen et al., 2015; Thomsen et al., 2017) . In mice and rats, a dose of 0.05 μg per side into the NTS was used since our dose response study established that this dose neither effects locomotor activity nor gross behavior in mice (Fig. 1A) and that a similar doses has been found to reduce food intake in rats (Reiner et al., 2016; Richard et al., 2015) . A lower dose of Ex4 (0.025 μg per side) was also tested in the alcohol intake studies in rats in order to establish a dose response effect of Ex4. Ex4 was always administered ten minutes prior to alcohol exposure. For systemic administration a Ex4 dose of 2.4 μg/kg (ip, diluted in 0.9% NaCl) was selected since it attenuates alcohol-related behaviors in mice, without having an effect on behaviors per se (Egecioglu et al., 2013c) . For local infusion into the NTS, exendin-3(9-39) (Ex9, Tocris Bioscience), a selective GLP-1R antagonist (Goke et al., 1995; Thorens et al., 1993) , was dissolved in vehicle (Ringer solution) and was administered 15 min prior to Ex4. Ex9 was administered at a dose of 5 μg per side into the NTS since this dose increases food intake following central infusion (Hayes et al., 2009; Williams et al., 2018) . Ex9 as well as Ex4 into the NTS was infused at a volume of 0.5 μl side over a period of 60 s. Following each experiment the rodents were decapitated and the brains were mounted on a vibroslice device (752 M Vibroslice; Campden Instruments Ltd., Loughborough, UK). The brains were cut in 50 μm sections, and the location of the probe and/or guide cannulas were verified (Franklin and Paxinos, 1996; Paxinos and Watson, 1998) . Only animals with correct placements were included in the statistical analysis ( Supplementary  Figs . 1A-C).
Guide and probe implantation
Mice were inserted with either a probe and/or guide targeting at nucleus accumbens (NAc) shell and NTS, respectively. Other mice or rats were implanted with bilateral guides targeting the medial and caudal part of the NTS, as preproglucagon neurons are located medially (Card et al., 2018) and as the caudal part of NTS contains the highest GLP-1R mRNA expression (Merchenthaler et al., 1999) . The rodent was anesthetized with isofluran (Isofluran Baxter, Apoteket AB, Gothenburg, Sweden) using a pump (Univentor 400 Anaesthesia Unit, Univentor Ldt., Zejtun, Malta), placed in a stereotaxic frame (David Kopf Instruments; Tujunga, CA, USA) and kept on a heating pad to prevent hypothermia. Xylocain (10 mg/ml) adrenalin (5 μg/ml) (Pfizer Inc, Apoteket AB, Gothenburg, Sweden) was used as local anesthetics and carprofen (Rimadyl®, 5 mg/kg ip, Astra Zeneca; Apoteket AB) to relieve pain. The skull bone was exposed and holes for the dialysis probe, guide (stainless steel, length 10 mm, with an o.d./i.d. of 0.6/0.45 mm) allowing local injections, and for the anchoring screw were drilled. The dialysis probe and/or the guide were anchored to the screw and the skull bone with dental cement (DENTALON ® plus; Agntho's AB, Lidingö, Sweden). The probe was randomly alternated to either left or right NAc shell, where dopamine is released following alcohol injection (Jerlhag et al., 2009 ). The coordinates of +1.4 mm anterior to the bregma, ± 0.6 mm lateral to the midline and 4.7 mm below the surface of the brain surface were used (Franklin and Paxinos, 1996) . For NTS, the following coordinates relative to bregma were used; posterior −7.4 mm and ± 0.5 mm lateral to midline (Franklin and Paxinos, 1996) for mice and posterior −13.4 mm and lateral ± 1.2 mm lateral to the midline (Paxinos and Watson, 1998) for rats. The guides were always inserted −1.0 mm below the surface of the brain and at the time of the experiment, the cannulas were extended another 3.3 mm in mice and 7.2 mm in rats ventrally beyond the tip of the guide aiming for drug administration into the NTS. In all experiments one hour before the NTS injections, a dummy cannula was inserted through the guide cannula to remove clotted blood and damper spreading depression.
Acute effect of alcohol
Locomotor activity experiments in mice
Locomotor activity was registered in six sound attenuated, ventilated and dim lit locomotor boxes (420 × 420 × 200 mm; Open Field D. Vallöf, et al. Neuropharmacology 149 (2019) 124-132 Activity System; Med Associates Inc, Gerogia, Vermont, USA), as previously described (Kalafateli et al., 2018) . In this system, 15 × 15 infrared beams at the bottom of the floor allow a computer-based system to register the distance travelled (cm per 5 min) of each mouse during 60 min. Prior to drug administrations the mice were allowed to habituate to the locomotor activity box for 60 min. The first experiment was designed to select a dose of Ex4 into the NTS without any effect per se. The mice were administered with either vehicle (Ringer) or Ex4 (0.05, 0.1 or 0.2 μg per side) bilaterally into the NTS. A dose of 0.05 μg per side was used further on since the doseresponse revealed that this dose hade no effect per se on locomotor activity (Fig. 1A) .
Thereafter, the effect of bilateral Ex4 (0.05 μg per side) administration into the NTS, on alcohol-induced (1.75 g/kg, ip) locomotor stimulation was evaluated. Therefore, mice received either Ex4 or vehicle in combination with either alcohol or vehicle creating the following treatment combination .
Finally, we evaluated the role of GLP-1R within the NTS for the ability of systemic Ex4 to attenuate the alcohol-induced locomotor stimulation in mice. Mice were therefore first treated with vehicle of Ex9 (5 μg per side) into the NTS. They thereafter received a systemic injection of Ex4 (2.4 μg/kg, ip) or vehicle. Finally, alcohol (1.75 g/kg, ip) or vehicle was injected systemically. The following treatment combinations were created; vehicle-vehicle-vehicle, Ex9-vehicle-vehicle, vehicle-vehicle-alcohol, vehicle-Ex4-alcohol or Ex9-Ex4-alcohol.
Conditioned place preference in mice
The present design of the CPP paradigm evaluated the effect of Ex4 (0.05 μg per side) on reward-dependent memory consolidation of alcohol (1.75 g/kg, ip) reinforcement. As described previously (Jerlhag et al., 2009 ), a two-chambered conditioned place preference apparatus (45 lux) with distinct visual and tactile cues was used. Thus, each CPP test consisted of pre-conditioning (day 1), conditioning (days 2-5), and post-conditioning (day 6). The initial place preference was determined after the mice were placed in the middle of the CPP box with 20-min free access to both compartments during pre-conditioning. Conditioning (20 min per session) was done using a biased procedure in which alcohol was paired with the least preferred compartment and vehicle with the preferred compartment. All mice received one alcohol and one vehicle injection every day and the injections were altered between morning and afternoon in a balanced design.
At the post-conditioning day the mice were either injected with Ex4 or an equal volume of vehicle bilaterally into NTS. The mice were then placed on the midline between the two compartments with free access to both compartments for 20 min (creating the following treatment groups; alcohol-vehicle and alochol-Ex4).
In addition, a control experiment was conducted to evaluate the effect of Ex4 in the NTS on CPP per se. These mice were subjected to the same procedure, but received vehicle injections instead of alcohol throughout the conditioning (non-alcohol conditioned). At post-conditioning the mice were injected locally and bilaterally with Ex4 (0.05 μg) or an equal volume of vehicle (Ringer) into the NTS. The mice were then placed on the midline between the two compartments with free access to both compartments for 20 min (creating the following two treatment groups vehicle-vehicle and vehicle-Ex4). Albeit alcohol-reward (when conditioning with alcohol) as well as conditioned taste aversion (when conditioning with vehicle) would be studied when Ex4-NTS precedes alcohol/vehicle on each conditioning day, these studies cannot be conducted since the behaviors of the rodents are influenced negatively following two local infusions on each conditioning day.
The expression of CPP was calculated as the difference in percent of total time spent in the drug-paired (i.e., less preferred) compartment during the post-conditioning and the pre-conditioning session.
In vivo microdialysis and dopamine release measurements in mice
The present experiment investigated the effects of Ex4 (0.05 μg) infusion into the NTS on alcohol-induced (1.75 g/kg, ip) release of dopamine in NAc shell, using microdialysis in freely moving mice. Therefore, mice were implanted with a microdialysis probe positioned in the NAc shell and an ipsilateral guide targeting the NTS as described above (see 2.3.).
On the day of the experiment the probe was connected to a microperfusion pump (U-864 Syringe Pump; AgnThós AB) and perfused with Ringer solution at a rate of 1.5 μl/min. After one hour of habituation to the microdialysis set-up, perfusion samples were collected every 20 min throughout the entire experiment. The baseline dopamine level was defined as the average of first three consecutive samples (−40 min until 0 min). After baseline samples, Ex4 or vehicle was administered (at 10 min) and 10 min later alcohol or vehicle was administered (at 20 min), creating the following treatment groups: vehicle-vehicle, vehicle-alcohol, Ex4-vehicle and Ex4-alcohol. Nine consecutive 20-min samples were thereafter collected. The challengeinduced increase in accumbal dopamine was calculated as the percentage of increase from the baseline samples.
Dopamine was separated and quantified using two different highperformance liquid chromatography apparatuses with electro chemical detection as described previously (Jerlhag et al., 2006) . In brief, a pump (UltiMate 3000 Pump; Thermo Scientific, Darmstadt, Germany), an ion exchange column (Nucleosil SA, 2.0 × 150 mm, 5 μm diameter, pore size 100 Å; Phenomenex Scandinavia, Västra Frölunda, Sweden) and a detector (Decade, Kovalent AB, Sweden) operated at 400 mV versus the cell were used. The mobile phase was delivered at 0.3 ml/min and consists of 58 mM citric acid, 135 mM NaOH, 0.107 mM Na2-EDTA and 20% methanol. The second system consisted of a pump (UltiMate 3000 Pump; Thermo Scientific, Darmstadt, Germany), a reversed phase column (2.0 × 50 mm, 3 μm diameter; pore size 100 Å; Phenomenex Scandinavia, Västra Frölunda, Sweden) and a detector (Dionex, Västra Frölunda, Sweden) operated at 220 mV versus the cell. The mobile phase was delivered at 0.3 ml/min and consists of f 150 mM NaH2PO4, 4.76 mM citric acid, 3 mM sodium dodecyl sulphate, 50 μM EDTA, as well as 10% MeOH and 15% acetonitrile. In addition, the effects of Ex4 or vehicle into the NTS on serotonin release in NAc shell was measured in this HPLC system (Supplementary Fig. 2 ).
Twelve weeks of intermittent access 20% alcohol two-bottle-choice drinking paradigm
The effect of two different Ex4 doses (0.05 μg per side, experiment one; 0.025 μg per side, experiment two) on alcohol intake in rats was investigated. All rats had free access to one bottle of 20% alcohol and one bottle of water during three 24-h-sessions per week (Mondays, Wednesdays and Fridays) (Simms et al., 2008) and the days in between they had unlimited access to two water bottles. Bottles and food were weighed at 24 h after the fluids were presented. The rats voluntarily consumed alcohol in this intermittent access model for 12 weeks. Thereafter, rats were subjected to local and bilateral administration of Ex4 (0.05 μg experiment one; 0.025 μg, experiment two) into the NTS and the effect on alcohol, water, total fluid and food intake, as well as preference for alcohol over water (the ratio of alcohol to total fluid intake) was registered at 1, 4 and 24 h after bottle presentation. Body weight change was measured at the 24-h time point. The effects on intake by Ex4 are always compared to vehicle rather than baseline, as infusions into the NTS might influence drinking per se.
Statistical analysis
The locomotor activity experiments were evaluated by one-way ANOVA followed by Tukey or Bonferroni post-hoc test for comparisons between different treatments. Dopamine release in NAc shell and locomotor activity over time were analyzed with a repeated measures D. Vallöf, et al. Neuropharmacology 149 (2019) 124-132 two-way ANOVA, followed by a Bonferroni post-hoc test for the comparison between different treatments at given time points. An unpaired t-test was used for CPP and alcohol drinking experiments.
Results
Effects of Ex4 administration into the NTS on alcohol-induced locomotor stimulation, the memory of alcohol reward in the CPP paradigm and accumbal dopamine release in male mice
The dose-response study reveled an overall main effect of treatment on locomotor activity in mice following intra Ex4-NTS infusion (0.05; 0.1 or 0.2 μg per side) (F(3,49) = 2.85, P = 0.0469). As shown in Fig. 1A there were no differences in response between vehicle (n = 17) and 0.05 μg (n = 15) treated mice. Albeit not significant, both 0.1 μg (n = 11) and 0.2 μg (n = 10) NTS-infusion visually reduced the locomotor activity as well as gross behaviors of the mice. An overall main effect of treatment was found on locomotor activity in mice following systemic administration of alcohol and intra-NTS injection of Ex4 (F(3, 28) = 3.43, P = 0.0011; n = 8 for all treatment groups). As shown in Fig. 1B , post-hoc analysis revealed that alcohol significantly increased locomotor activity compared to vehicle (P < 0.001). The alcohol response was significantly lower in Ex4 treated mice compared to vehicle treated mice (P < 0.05), while there was no difference in locomotor activity response in vehicle treated mice and Ex4-alcohol treated mice (P > 0.05), showing that intra-NTS Ex4 attenuates alcohol-induced locomotor stimulation. The selected dose of Ex4 had no effect per se on locomotor activity compared to vehicle treatment (P > 0.05). For the analysis of locomotor activity over time showed an overall main effect of treatment (F(3,21) = 7.82, P = 0.0011), time (F(11,77) = 1.23, P = 0.2832) as well as of treatment × time interaction (F (23,231) = 0.63, P = 0.9453) (Fig. 1C , n = 8 in each treatment group). Post-hoc analysis demonstrated that alcohol (vehicle-alcohol) increased the locomotor activity compared to vehicle (vehicle-vehicle) at time points 30 min (P < 0.01) and 50 min (P < 0.05). Intra-NTS-Ex4 administration (Ex4-alcohol) significantly blocked the alcohol-induced locomotor stimulation at time points 30 min (P < 0.01) and 50 min (P < 0.05). This attenuation of alcohol-induced locomotor stimulation Fig. 2 . Nucleus of the solitary tract administration of exendin-4 decreased alcohol intake in rats consuming alcohol for twelve weeks. In comparison to vehicle (Veh), Exendin-4 (Ex4; 0.05 μg per side) infusion into the nucleus of the solitary tract (NTS) reduced alcohol intake in rats at (A) 1-h, (B) 4-h and (C) 24-h time points. (D) Ex4-NTS had no effect on alcohol preference at 1-h time point compared to vehicle. There was a tendency in reduction at the (E) 4-h time point, and a decline in alcohol preference at the (F) 24-h time point following NTS-Ex4 injection was obtained. Ex4 into the NTS had no effect on water intake at (G) 1-h, (H) 4-h or (I) 24-h time points. Data are presented as mean ± SEM (*P < 0.05, **P < 0.01, un-paired t-test).
is further substantiated, as there were no differences in response between vehicle and Ex4-alcohol treated mice at any time point (P > 0.05). Compared to vehicle, there was no difference in locomotor activity following Ex4-NTS at any time points (P > 0.05).
In comparison to vehicle, Ex4 into the NTS (Alc-Ex4, n = 8) inhibited the memory consolidation of alcohol reward in the CPP paradigm (P = 0.015, n = 8 per group, Fig. 1D ). Control experiments showed that there were no differences in CPP (%) response (P = 0.9130) between intra-NTS Ex4 (vehicle-Ex4, -11.5 ± 10.9, n = 8) and vehicle (vehicle-vehicle, −9.6 ± 13.2, n = 7).
Microdialysis measurements of dopamine release in NAc shell in mice revealed an overall main effect of treatment (F(3,273) = 54.30, P < 0.0001), time (F(12,91) = 4.36, P < 0.0001) as well as of treatment × time interaction (F(36,273) = 1.87, P = 0.0029) (Fig. 1E , n = 8 in each treatment group). Post-hoc analysis demonstrated that the dopamine levels in NAc shell were elevated following alcohol injection (40-60 min (P < 0.05), 80 min (P < 0.01), 100 min (P < 0.05), 120-140 min, (P < 0.01), 160 min, 180-200 min (P < 0.01); vehicle-alcohol) compared to vehicle treatment (vehiclevehicle). Intra-NTS-Ex4 administration (Ex4-alcohol) significantly attenuated the ability of alcohol to increase accumbal dopamine at time point 60, 80, 100 min (P < 0.05) and at 180 min (P < 0.001). This blockade of alcohol-induced dopamine release is further supported by the findings that there were no differences in response between vehicle and Ex4-alcohol treated mice at any time point (P > 0.05). In comparison to vehicle treatment, there was no difference in dopamine levels following Ex4 infusion into NTS at any time points (P > 0.05).
Effects of infusion of two different Ex4 doses into the NTS on alcohol intake in male rats
In experiment one (0.05 μg Ex4), there were no differences (P = 0.6398) in baseline alcohol intake (g/kg/24hrs) in rats later infused with vehicle (6.1 ± 0.5, n = 6) or Ex4 (5.9 ± 0.2, n = 8) into the NTS. In comparison to vehicle, Ex4 (0.05 μg per side) decreased the alcohol intake at 1-h (P = 0.0101, Fig. 2A ), 4-h (P = 0.0017, Fig. 2B ) and 24-h (P = 0.0352, Fig. 2C ) time points in rats consuming alcohol for 12 weeks. There was no difference between treatments in alcohol preference at 1-h (P = 0.2135, Fig. 2D ) time points. However, there was tendency in reduction of the 4-h alcohol preference by Ex4 (P = 0.0639, Fig. 2E ). At the 24-h time point the preference of alcohol over water was lower in Ex4 compared to vehicle treated rats at (P = 0.0368, Fig. 2F ). There were no treatment differences in water intake at 1-h (P = 0.3126, Figure 2G ), 4-h (P = 0.3524, Fig. 2H ) or 24-h (P = 0.3637, Fig. 2I ) time points. Neither were there any differences in total fluid intake at 1-h (P = 0.8980), 4-h (P = 0.7895) nor 24-h (P = 0.9267) time points in the vehicle and Ex4 groups ( Supplementary  Figs. 3A-C) . Additionally, Ex4 did not affect the food intake at 1-h (P = 0.5539), 4-h (P = 0.5849) or 24-h (P = 0.9672) time points ( Supplementary Figs. 3D-F) or the 24-h body weight change (g) (P = 0.5566; vehicle −5.5 ± 2.6 and Ex4 -7.9 ± 2.8).
In experiment two (0.025 μg Ex4), there was no difference (P = 0.8601) in baseline alcohol intake (g/kg/24hrs) in rats later infused with vehicle (4.0 ± 0.5, n = 5) or Ex4 (4.1 ± 0.7, n = 5) into the NTS. Albeit a low number of rats in this study, compared to vehicle, Ex4 (0.025 per side) had no effect on alcohol intake at 1-h (P = 0.8747), 4-h (P = 0.8520, Fig. 3A) or 24-h (P = 0.7411, Fig. 3B ) time points in rats drinking alcohol for 12 weeks (Fig. 3C) . Ex4 treatment did not alter alcohol preference at 1-h (P = 0.1412), 4-h (P = 0.3188) or 24-h (P = 0.0970) time points ( Supplementary  Figs. 4A-C ). There were no differences in water intake at 1-h (P = 0.0721), 4-h (P = 0.1305) or 24-h (P = 0.0953) time points following Ex4 or vehicle infusion ( Supplementary Figs. 4D-F) . There was a tendency in an increased total fluid intake at 1-h (P P= 0.0563) time point by Ex4 infusion. However, there were no differences in total fluid intake at time points 4-h (P = 0.1454) or 24-h (P = 0.0845) between treatment groups (Supplementary Figs. 4G-I) . In comparisons to vehicle, Ex4 did not affect food intake at 1-h (P = 0.4901), 4-h (P = 0.8922) or 24-h (P = 0.9103) time points ( Supplementary Fig. 4J -L). Ex4 had no effect on the 24-h body weight change (g) (P = 0.9628; vehicle −9.0 ± 3.7 and Ex4 -9.2 ± 1.9).
Effects of Ex9-NTS infusion on the ability of systemic Ex4 to attenuate the alcohol-induced locomotor stimulation in mice
An overall main effect of treatment was found on locomotor activity in mice following intra-NTS injection of Ex9 in combination with systemic administration of Ex4 and alcohol (F(4, 52) = 4.48, P = 0.0035; n = 11 for vehicle-vehicle-vehicle and vehicle-Ex4-alcohol, n = 12 for Ex9-Ex4-alcohol, n = 13 for Ex9-vehicle-vehicle). As shown in Fig. 4 , post-hoc analysis revealed that alcohol significantly increased the locomotor activity compared to vehicle (P < 0.05). There was no difference in locomotor response in vehicle-vehicle-vehicle compared to vehicle-Ex4-alochol treated mice (P > 0.05). Compared to vehicle, alcohol induced a locomotor stimulation in mice pre-treated with Ex9-NTS and Ex4 systemically (P < 0.05). The alcohol response was similar in Ex9-Ex4-alcohol treated mice compared to vehicle-vehicle-alcohol treated mice (P > 0.05). The selected dose of Ex9 had no effect per se on locomotor activity compared to vehicle treatment (P > 0.05).
Discussion
The present study expands on the known physiological role of NTS-GLP-1R as regulators of food intake and body weight, by identifying that activation of these receptors suppresses alcohol-related behaviors. Indeed, Ex4 administration into the NTS, at a dose with no effect per se on reward-related parameters or gross behavior, blocks alcohol-induced locomotor stimulation, accumbal dopamine release and memory consolidation of alcohol reward in the CPP paradigm in mice. Furthermore, Ex4-NTS injections dose-dependently reduce alcohol intake in alcoholconsuming rats at all measured time points. Additionally, the noted robust decline in alcohol consumption was accompanied by reduction in alcohol preference over water. Our data are in line with previous preclinical studies reporting that activation of NTS-GLP-1R reduces food reward (Alhadeff and Grill, 2014; Richard et al., 2015) as well as nicotine intake (Tuesta et al., 2017) . The above findings collectively suggest that activation of GLP-1R within the NTS regulates reward from food as well as drugs of abuse, although the underlying mechanisms remain to be elucidated.
Our findings that NTS-Ex4 attenuates the established effects of acute alcohol on the mesolimbic dopamine system (Doyon et al., 2003; Ericson et al., 2003; Sanchis-Segura and Spanagel, 2006) , possibly suggest that GLP-1R dependent connectivity from the NTS to areas of this dopamine system prevents the ability of alcohol to activate it. This is substantiated by the findings that NTS afferents target the ventral tegmental area (VTA) as well as NAc (Alhadeff et al., 2012; Jin et al., 1988; Merchenthaler et al., 1999; Rinaman, 2010) and that intra-NTS Ex4 microinjection increases expression of dopamine related genes in the VTA (Richard et al., 2015) . This connection is also indirectly supported by the findings that local administration of Ex4 into NAc reduces alcohol intake in female rats (Abtahi et al., 2018) and that activation of GLP-1R in the VTA reduces cocaine seeking in male rats (Hernandez et al., 2018) . Tentatively, Ex4 may also through activation of NTS-GLP-1R reduce the activity of NTS projections to laterodorsal tegmental area (LDTg) (Reiner et al., 2018) , another area regulating alcohol-mediated behaviors and functionally connected to the mesolimbic dopamine system (Larsson et al., 2005) . A physiological role of LDTg GLP-1R is provided by the rat data showing that Ex4 into this area causes a reduction in body weight as well as food intake (Reiner et al., 2018) . Although activation of GLP-1R sensitive NTS afferents to reward areas including NAc, VTA and LDTg, might provide a possible downstream circuitry for the ability of Ex4-NTS to attenuate alcohol-mediated behaviors, other downstream brain areas should also be considered as potential mediators (Llewellyn-Smith et al., 2011) .
The present study also revealed that Ex9 into the NTS prevent the ability of systemic Ex4 to block the alcohol-induced locomotor stimulation, indicating that GLP-1R within the NTS regulate the ability of systemic Ex4 to regulate the behavioral responses to alcohol. However, as Ex4 passes the blood brain barrier and penetrates the brain the possibility should be considered that GLP-1R within other brain areas also modulate this attenuating effect of systemic Ex4.
Activation of NTS-GLP-1R, that are expressed presynaptically rather than on preproglucagon neurons (Hayes et al., 2010; Hisadome et al., 2010; Vrang et al., 2007) , may also prevent alcohol's behavioral effects via local NTS-dependent mechanisms. Indeed, previous studies have established that acute systemic alcohol, morphine or cannabis injections activate this area as measured by increases in c-FOS like immunoreactivity (Lee et al., 2011; Olson et al., 2006; Rodriguez de Fonseca et al., 1997; Smith and Aston-Jones, 2008; Thiele et al., 2000) . A potential mechanism through which alcohol utilizes NTS function is provided by the electrophysiological data demonstrating that alcohol enhances presynaptic GABA release, which in turn prevents subsequent GABA release by interneurons (Aimino et al., 2018) . This disinhibition would in turn increase activity of tyrosinhydroxylase positive noradrenaline neurons in the NTS, which are known to project to NAc (Delfs et al., 1998; Wang et al., 1992) . It should therefore be considered, that activation of NTS-GLP-1R inhibits alcohol-related behaviors by preventing this GABA-GABA-noradrenaline connectivity.
The present study also demonstrates that Ex4 administration into the NTS on the post-conditioning day blocks the memory of alcohol reward in the CPP test in mice. A regulatory role of GLP-1R in the NTS for memory reward is further strengthened by the findings that injections of Ex4 into the NTS block memory consolidation of food reward in the CPP paradigm (Alhadeff and Grill, 2014; Richard et al., 2015) and that systemic administration of Ex4 attenuates the memory of alcohol reward in the CPP paradigm (Egecioglu et al., 2013c) . Albeit no effect by NTS-GLP-1R activation on food intake and body weight was observed herein, direct injections of Ex4 into the NTS have previously been shown to reduce chow (Alhadeff and Grill, 2014; Reiner et al., 2016) and high fat diet intake, as well as to decrease body weight (Alhadeff and Grill, 2014) . The suppressive effect on food intake caused by GLP-1R activation within the NTS is further supported by findings from NTS-GLP-1R knockout mice, which show increased food intake compared to wild type, without altered body weight (Alhadeff et al., 2017) . Similarly, rats display a reduction in chow intake following Ex4 into NTS when chow is the sole source of food offered (Richard et al., 2015) . However, in a choice setting, intra-NTS Ex4 treatment selectively reduces palatable food intake, rather than chow (Richard et al., 2015) . A differential Ex4-effect on consummatory behavior is substantiated by our findings that Ex4 into the NTS significantly reduces alcohol intake without affecting water intake or other parameters, such as food intake or body weight. Taken together, this could imply that the chow suppressing effect of NTS-Ex4 depends on the context such as food restriction or choice situation.
Nevertheless, certain limitations of this study need to be taken into consideration. Indeed, rats are influenced by surgeries, implantations and intracranial injections as demonstrated by a reduction in intake from baseline in both the vehicle and Ex4 groups. However, to minimize impact of this, vehicle controls were included in the study design and animals with signs of intracranial bleeding were excluded. Albeit the present infusions target the NTS, the possibility should be considered that GLP-1R in other nearby areas such as area postrema, which innervates the NTS as well as sense peripheral GLP-1 signals (Yamamoto et al., 2003) , are activated by Ex4 diffused to surrounding areas. This appears less likely since a low volume (0.5 μl) that is less likely to diffuse was used and since the few miss-placed infusions of Ex4 (too low to do statistical analysis on) did not attenuate the alcoholresponse. Ex4-induced aversion, a well-known effect of GLP-1R agonists (Kanoski et al., 2012) , could be a potential factor influencing the interpretation of the present data. However, this appears less likely, since the selected doses of Ex4 have no effect on water intake and neither of the intra-NTS Ex4 doses (0.025 or 0.05 μg) (Alhadeff and Grill, 2014; Richard et al., 2015) alters kaolin intake. In addition, effect of Ex4 on As evident in Fig. 4 , in comparison to vehicle (Veh) alcohol (Alc) causes a locomotor stimulation in vehicle treated mice, but not in mice pre-treated systemically with exendin-4 (Ex4). Moreover, alcohol caused a locomotor stimulation in mice pre-treated with exendin-3(9-39) (Ex9) into the NTS in combination with Ex4 systemically. There was no difference in locomotor activity in vehicle treated mice and in those infused with Ex9 into the NTS. (*P < 0.05, n.s. P > 0.05, one-way ANOVA followed by Bonferroni post-hoc test). gross behavior can be excluded, since no effect on accumbal dopamine release or locomotor activity was observed after NTS injections of Ex4. Another limitation with the present study is that the behavioral response to Ex4-NTS and alcohol was only explored in male rodents, and therefore future studies on female rodents warranted.
In conclusion, the present data extend the knowledge gap by demonstrating that activation of GLP-1R in NTS suppresses alcohol-related behaviors. In addition, they support the previously described role of GLP-1R in alcohol reinforcement (Egecioglu et al., 2013c; Sorensen et al., 2016; Suchankova et al., 2015; Thomsen et al., 2017; Vallof et al., 2016a) and provide an indication of the neural circuits through which systemic administration of GLP-1 receptor agonists may regulate behavioral responses to alcohol.
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